SVRA

SAVARA INC

SVRA·805111101·US·Common Stock·Healthcare - Biotechnology-Activist

SVRA (SAVARA INC) is held by 112 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($61.6M), Polar Capital Holdings Plc ($52.1M), VANGUARD CAPITAL MANAGEMENT LLC ($42.5M). Net institutional sentiment: Bullish.

112
Holders
Avg rating(23 Elite)
$437.6M
Total Value
69% (120)
Fund Consensus
77 buying - 34 selling
SVRASmart Money Verdict
View all
Held by 112 funds
23 elite
Who's Trading
ActivistTCTCG Crossover GP I, LLC6.1%Feb 17, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.9%Feb 17, 2026
ActivistNANantahala Capital Management, LLC3.6%Feb 13, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.4.1%Feb 13, 2026
ActivistFAFarallon Capital Partners, L.P.1.2%Feb 5, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.4%Jan 21, 2026
InsiderRARAMSAY DAVID ASell $121KDec 19, 2025
InsiderHJHawkins Richard JBuy $99KJun 20, 2025
InsiderMSMcCracken Joseph SBuy $21KMay 29, 2025
InsiderRARAMSAY DAVID ABuy $416KMar 31, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.3M(+1.8%)$61.6M0.0%+57.47%
30
Increased
9.5M(+14.9%)$52.1M0.2%-0.19%
40
New
7.8M$42.5M0.0%+8.06%
40
Increased
6.7M(+54.8%)$36.6M0.0%+13.68%
41
Unchanged
6M$32.5M0.3%-1.31%
0
Decreased
4.5M(-1.0%)$24.6M0.0%-1.31%
0
Increased
4.2M(+0.0%)$23.2M0.1%+0.74%
28
Increased
3.6M(+5.2%)$19.6M0.0%+52.10%
30
Increased
2.7M(+1.3%)$14.8M0.0%+38.75%
28
New
2.3M$12.4M0.0%+8.06%
39
Increased
2.1M(+26.5%)$11.5M0.0%+9.16%
34
Decreased
1.8M(-23.6%)$9.8M0.0%+51.50%
0
New
1.4M$7.5M0.0%+8.06%
38
Increased
1.2M(+10.4%)$6.5M0.0%+50.16%
30
Decreased
1.1M(-1.8%)$6.2M0.0%+43.18%
0
Decreased
1.1M(-0.8%)$5.7M0.0%-1.31%
0
New
1M$5.5M0.0%+8.06%
37
Increased
848,391(+2.9%)$4.6M0.0%+27.38%
28
Increased
798,735(+3.1%)$4.4M0.0%+54.55%
28
Increased
756,774(+0.7%)$4.1M0.0%+141.47%
27

Showing 1-20 of 120

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used